Pharmascience will discontinue several barbiturates

April 2003

Pharmascience will discontinue several barbiturates...

amobarbital/secobarbital (Tuinal)...amobarbital (Amytal)... secobarbital (Seconal).

The company is having a tough time getting raw materials.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

which drug to use for the initial treatment of hypertension
Diabetes Avandamet, the first combo tablet containing rosiglitazone plus metformin
caffeine might reduce the efficacy of methotrexate for rheumatoid arthritis
Cardiology rumour that enteric-coated ASA doesn't work for preventing cardiovascular disease
Cardiology new ACE inhibitor, Mavik (trandolapril) by Abbott
Dermatology latest treatments for rosacea
Women s Health Today Sponge is finally back
Renal Urology alpha-blockers for urinary problems in WOMEN
HIV drug, Fuzeon (enfuvirtide), approved in the U.S
Pharmascience will discontinue several barbiturates
Zyprexa (olanzapine) is now approved in Canada to treat bipolar MANIA
Natural Medicines anti-aging supplements that appear to contain growth hormone
Obesity Weight Loss Meridia (sibutramine) for obesity is safe
Gastroenterology A new formulation of Kaopectate in the U.S. is creating lots of confusion
Pneumonia theories on how the deadly pneumonia known as SARS is being transmitted